Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study

[1]  F. Baroody.  Nonallergic Rhinitis: Mechanism of Action. , 2016, Immunology and allergy clinics of North America.

[2]  J. Bernstein,et al.  Nonallergic Rhinitis: Diagnosis. , 2016, Immunology and allergy clinics of North America.

[3]  S. Johnston,et al.  Effect of fluticasone propionate on virus-induced airways inflammation and anti-viral immune responses in mice , 2015, The Lancet.

[4]  R. Gagliardo,et al.  Cigarette smoke alters non-neuronal cholinergic system components inducing MUC5AC production in the H292 cell line. , 2014, European journal of pharmacology.

[5]  Ivana V. Yang,et al.  Muc5b is required for airway defence , 2013, Nature.

[6]  J. Sallenave,et al.  Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs , 2012, Proceedings of the National Academy of Sciences.

[7]  Geng Xu,et al.  Sensitivity of MUC5AC to Topical Corticosteroid is Negatively Associated with Interleukin-17A in Patients with Allergic Rhinitis , 2012, American journal of rhinology & allergy.

[8]  B. Rubin,et al.  IL‐13‐induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  G. Ciprandi,et al.  Role of nasal cytology. , 2010, International journal of immunopathology and pharmacology.

[10]  L. Fabbri,et al.  MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients , 2009, Histopathology.

[11]  E. Lillehoj,et al.  Effects of dexamethasone on Muc5ac mucin production by primary airway goblet cells. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[12]  I. Adcock,et al.  Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease , 2004, Histopathology.

[13]  L. Fabbri,et al.  Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. , 2003, Thorax.

[14]  H. Ishinaga,et al.  Effects of Dexamethasone on Mucin Gene Expression in Cultured Human Nasal Epithelial Cells , 2002, The Laryngoscope.

[15]  A. Nicholson,et al.  Expression of respiratory mucins in fatal status asthmaticus and mild asthma , 2002, Histopathology.

[16]  R. Dahl,et al.  Mode of action of intranasal corticosteroids. , 2001, The Journal of allergy and clinical immunology.

[17]  Ferrié,et al.  Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  H. Boushey,et al.  Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. , 1998, The European respiratory journal.

[19]  F. Macgregor,et al.  Topical corticosteroids potentiate mucin secretion in the normal nose. , 1996, Clinical otolaryngology and allied sciences.

[20]  Z. Marom,et al.  Mucin genes are regulated by estrogen and dexamethasone. , 1995, Biochemical and biophysical research communications.

[21]  M. Lohmann‐Matthes,et al.  Pulmonary macrophages. , 1994, The European respiratory journal.

[22]  E. Meltzer,et al.  Nasal Cytology in Clinical Practice , 1988 .